CONTEXT: Inflammatory myofibroblastic tumors are a rare type of soft-tissue tumor. Inflammatory myofibroblastic tumors are characterized by rearrangements involving the anaplastic lymphoma kinase gene locus on 2p23. CASE REPORT: We report the case of a 67-year-old Chinese male who presented with dysuria and fever. Magnetic resonance imaging showed an irregular prostatic mass with an isointense signal and obscure boundary. Histopathological evaluation showed that the mass consisted mainly of spindle-shaped cells. Immunohistochemical evaluation showed that the tumor cells were negative for anaplastic lymphoma kinase. CONCLUSIONS: Inflammatory myofibroblastic prostate tumors are rare lesions with unclear etiology. The pathological diagnosis is very important.
INTRODUCTION
Inflammatory myofibroblastic tumors can be found in various parts of the body and are fre- treat prostate hyperplasia in a 67-year-old man is presented in this report.
CASE REPORT
A 67-year-old Chinese male presented with dysuria and fever for a month. He had a history of transurethral resection of the prostate to treat prostate hyperplasia four years earlier. Laboratory tests such as blood count and urinalysis were within the normal range. His serum total prostate-specific antigen level was 8.49 ng/ml (normal reference range: 0.00-4.00 ng/ml) and his free prostate-specific antigen level was 1.42 ng/ml (normal reference range: 0.00-0.93 ng/ml).
Subsequently, multiple echoless masses and calcification were found using ultrasonography.
Magnetic resonance imaging then demonstrated an irregular prostatic mass with an obscure boundary and isointense signal on T1 and T2-weighted images ( Figure 1A and Figure 1B ).
The lesion showed obvious enhancement in the early phase, on a contrast-enhanced magnetic resonance imaging scan (Figure 2) . Multiple enlarged lymph nodes were found in the right iliac vascular area and in the inguinal area bilaterally.
A transperineal biopsy of the prostate was performed on this lesion because the diagnosis was still unclear. Histopathological evaluation showed that the mass consisted mainly of spindle-shaped cells and a chronic inflammatory component consisting of plasma cells ( Figure 3A) .
Immunohistochemical evaluation showed that the tumor cells were positive for myoepithelial markers, including desmin, calponin, vimentin, actin and smooth muscle actin ( Figure 3B-E) , but that they were negative for CD117, CD10, S100 and anaplastic lymphoma kinase ( Figure 3F ). Inflammatory myofibroblastic tumors can be found primarily in children and young adults, and they rarely occur in patients over 40 years old. 7 Although inflammatory myofibroblastic tumors are more commonly recognized in the lungs, they can also be observed in several other sites including the breasts, liver, spleen, thyroid, pancreas, urinary tract, peritoneum, retroperitoneum, lymph nodes, gastrointestinal tract and central nervous system. 8 Inflammatory myofibroblastic tumors of the urinary tract have been reported more often in the kidneys.
Prostatic inflammatory myofibroblastic tumors are extremely rare. Since the first case in 2012, only one further case of inflammatory myofibroblastic prostate tumor has been reported ( Table 1) . 1, 2 In the present case, we reported that an inflammatory myofibroblastic tumor was found in an elderly man after transurethral resection of the prostate to treat prostate hyperplasia. This case was negative for anaplastic lymphoma kinase. Neither of the previous reports of prostatic inflammatory myofibroblastic tumors measured anaplastic lymphoma kinase levels.
One of these patients suffered from recurrence and distant metastasis and subsequently died.
1,2
The patient of our report did not express anaplastic lymphoma kinase. No further specific treatment was provided. The patient was followed up for two years and no evidence of recurrence or metastasis was noted. This suggests that treatment approaches for inflammatory myofibroblastic tumor patients can vary and surgery may not be essential.
CONCLUSION
In conclusion, prostatic inflammatory myofibroblastic tumors are rare lesions with unclear etiology. A definitive diagnosis cannot be made from symptoms, laboratory testing and imaging studies. The pathological diagnosis is very important. Regarding treatment methods, although surgery is not essential for treating prostatic inflammatory myofibroblastic tumors that are negative for anaplastic lymphoma kinase expression, long-term follow-up is necessary.
